« Previous article
All-in-One Kits and ...

27th August 2019  Content supplied by: Roche Diagnostics

High Throughput, Automated Testing of Four STIs From One Patient Sample


The addition of Trichomonas vaginalis (TV), and Mycoplasma genitalium (MG) tests to the FDA cleared cobas® testing menu means laboratories can now simultaneously process, from a single patient sample a combination of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and Mycoplasma genitalium (MG), which provides clinicians the information they need to screen and diagnose sexually transmitted infections (STIs) and improve patient care.

The addition of the cobas TV/MG test continues the expansion of the testing menu on the cobas 6800/8800 Systems, supporting true consolidation and testing efficiencies. The cobas TV/MG test has been validated for use with broad specimen types, including sample types comparable to those available for use with the cobas CT/NG test: male/female urine; endocervical swabs and vaginal swabs (both clinician collected and patient collected in a clinical setting).

The fully automated cobas 6800/8800 Systems offer the fastest time to results with the highest throughput and the longest walk-away time available among automated molecular platforms, providing laboratories with improved operating efficiency and the flexibility to adapt to changing testing demands.

 

 


    

Tags:

Date Published: 27th August 2019

Source article link: Roche Diagnostics


View full company details


Related news